MassMutual Private Wealth & Trust’s Axsome Therapeutics AXSM Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13K	Sell	53 -1	-2%	-$217	﹤0.01%	1284
2026 Q1	$9.13K	Buy	54 +2	+4%	+$345	﹤0.01%	1409
2025 Q4	$9.5K	Sell	52 -1	-2%	-$140	﹤0.01%	1413
2025 Q3	$6.44K	Sell	53 -53	-50%	-$5.97K	﹤0.01%	1579
2025 Q2	$11.1K	Sell	106 -32	-23%	-$3.39K	﹤0.01%	1320
2025 Q1	$16.1K	Buy	138 +132	+2,200%	+$15K	﹤0.01%	1121
2024 Q4	$508	Buy	+6	New	+$552	﹤0.01%	2139
2023 Q1	–	Sell	-4	Closed	–	–	1808
2022 Q4	$0	Buy	+4	New	+$239	﹤0.01%	1642

Other funds holding AXSM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MassMutual Private Wealth & Trust's AXSM Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its Axsome Therapeutics (AXSM) stake by 1.9% in Q2 2026, selling an estimated $217 and leaving 53 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1284.

MassMutual Private Wealth & Trust first reported a position in AXSM in Q4 2022 and has held it in 8 quarters since. The position peaked at $16.1K in Q1 2025. 121 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

MassMutual Private Wealth & Trust held 53 shares of Axsome Therapeutics worth $13K as of Q2 2026.
MassMutual Private Wealth & Trust sold 1 Axsome Therapeutics share in Q2 2026, an estimated $217.
Axsome Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1284 holding.
MassMutual Private Wealth & Trust first reported a position in Axsome Therapeutics in Q4 2022 and has held it in 8 quarters since.
MassMutual Private Wealth & Trust's Axsome Therapeutics position peaked at $16.1K in Q1 2025.
121 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.